Treatment of Pregnant Women With OUD
Key facts
- Who runs it
- Yale University
- Where
- Beverly, Boston, Concord, Hartford, Lowell, New Britain, New Haven, New London, Norwich, and Springfield, United StatesSee the 11 sites
- Trial code
- Status
- Completed
- People taking part
- 230 people enrolled
- Started
- 18 Jun 2020
- Ended
- 10 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Collaborative Care (CC)
- Extension for Community Healthcare Outcomes (ECHO)
- Record updated
- 21 May 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Provision of signed and dated informed consent form
- Females age 18 or older
- Documented pregnancy in the medical record at less than 34 weeks gestation
- Delivery date no later than July 1, 2024
- Willingness to adhere to the study schedule
- Confirmed opioid use disorder by the DSM-5 Opioid Use Disorder questionnaire
- Ability to communicate in English
- No current plan to move out of the obstetrical provider treatment area within the study timeframe of approximately 44 weeks
Who cannot take part
- Experiencing cognitive or emotional impairment that precludes the participant from providing informed consent
- Current hospitalization, incarceration, or institutionalization (if women present for care after institutionalization, participation is possible
- Current court case pending that would make incarceration likely during the study treatment period (approximately 44 weeks)
Where in United States
- Essex County ObGynBeverly, United States
- Beth Israel Deaconess Medical CenterBoston, United States
- AFA Obstetrics & GynecologyConcord, United States
- Hartford HospitalHartford, United States
- Women's Health, Lowell General HospitalLowell, United States
- Hospital of Central CTNew Britain, United States
- Yale New Haven Hospital Maternal Fetal Medicine UnitNew Haven, United States
- Yale New Haven Hospital Women's Center/Hill Health CenterNew Haven, United States
- Coastal ObGyn & MidwiferyNew London, United States
- OB Gyn Services PCNorwich, United States
- Wesson's Women's Clinic UMASS BaystateSpringfield, United States
About the trial
What the trial wants to find out
The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)
The 2 groups in the trial
- Collaborative Care (CC)Treatment being tested
The CC team includes an obstetrical provider and a nursing case manager. The obstetrician will see all participants, initially to discuss preferences for addiction treatment, buprenorphine, methadone (MAT) or no MAT. The obstetrician will see participants every 1-2 weeks, as needed and will provide prenatal care. The care team will meet at least monthly and review the participants' status. For research purposes, the CM will obtain informed consent, collect and enter results of the urine drug screen (UDS) into a database. At enrollment and at 26 and 34 weeks' gestation the care manager will ask participants to complete an assessment battery of self-reported measures.
- Extension for Community Healthcare Outcomes (ECHO)Existing treatment, for comparison
ECHO is a remote education model that provides mentorship and guided practice and participation in a learning community, via video conferencing. The practice members who participate in ECHO will include obstetricians and nurses as well as other members of the care team who wish to join. Providers are given access to a password-protected website containing the recorded sessions, a discussion board, and resource library. CME credits are available for each session and can motivate providers to attend.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Support Models for Addiction Related Treatment (SMART) Trial of Opioid Use Disorder OUD) in Pregnant Women
- Publications
- Reporting Perinatal Substance Use to Child Protective Services: Obstetric Provider Perspectives on the Impact on Care.Journal of women's health (2002), 2024
- Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics.PloS one, 2022
- Record updated
- 21 May 2025